非小细胞肺癌外科及辅助技术的研究进展  

Advances in surgical and assistive techniques for non-small cell lung cancer

作　　者：黄武浩 岳东升 Huang Wuhao;Yue Dongsheng(Department of Lung Cancer,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Tianjin Key Laboratory of Cancer Prevention and Therapy,Tianjin’s Clinical Research Center for Cancer,Tianjin Lung Cancer Center,Tianjin 300060,China)

机构地区：[1]天津医科大学肿瘤医院肺部肿瘤科、国家恶性肿瘤临床医学研究中心、天津市肿瘤防治重点实验室、天津市恶性肿瘤临床医学研究中心、天津市肺癌诊治中心,天津300060

出　　处：《中国肿瘤临床与康复》2025年第1期8-15,共8页Chinese Journal of Clinical Oncology and Rehabilitation

基　　金：国家自然科学基金面上项目(82173038);天津市医学重点学科(专科)建设项目(TJYXZDXK-010A)。

摘　　要：近年来,随着肺癌筛查的普及和技术的提高,可切除非小细胞肺癌(NSCLC)的比例不断增高,其中包括许多含磨玻璃样成分(GGO)的早期NSCLC。外科治疗理念也随之发生改变,对于早期NSCLC,肺癌手术切除范围由肺叶切除向亚肺叶切除转变,肺癌手术变得更加精准化、精细化和微创化。肺癌患者在得到更好的手术治疗的同时,术后并发症变少,康复效果也更好。文章围绕可手术NSCLC的外科治疗理念变革及相关技术的发展应用进行阐述。In recent years,with the popularization of lung cancer screening and advancements in technology,the proportion of resectable non-small cell lung cancer(NSCLC)has continuously increased,including many early-stage NSCLC with ground-glass opacity(GGO)components.Surgical treatment concepts have also evolved accordingly.For early-stage NSCLC,the scope of lung cancer surgery has shifted from lobectomy to sublobar resection,making lung cancer surgery more precise,refined,and minimally invasive.As a result,lung cancer patients benefit from better surgical treatment,with fewer postoperative complications and improved recovery outcomes.This article focuses on the evolution of surgical treatment concepts and the development and application of related technologies in operable NSCLC.

关 键 词：癌 非小细胞肺 亚肺叶切除 电磁导航支气管镜 机器人手术 无管化胸腔镜手术 

分 类 号：R73[医药卫生—肿瘤]